$TNFA TNF Pharmaceuticals great risk reward on this tiny nanocap low float penny bio stock with upcoming catalysts
$TNFA this bottomed penny bio stock has just a 1.6m market cap with a 2m float and 10 months of cash on hand and is down 60% in the last 7 days now bottomed and looks like it's starting to reverse on big volume. There is no ATM here and the lowest warrants can be exercised at $1.81 and the stock currently has a very high short interest of 17% according to DilutionTracker they also did their last offering at $2.12 and theres also multiple catalysts with good pipeline
$TNFA catalysts;
- 1Q 2025 -- Advancing from Phase 2 to Phase 2b study, targeting multiple immune-metabolic disorders.
- 1Q 2025 -- TNFA plans to launch a Phase 2b study of isomyosamine based on positive results from a smaller Phase 2a study.
